• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Research Brief on 2,2-dimethyl-3-(5-propylthiophen-2-yl)propan-1-amine (CAS: 2228572-71-0): Recent Advances and Applications

The compound 2,2-dimethyl-3-(5-propylthiophen-2-yl)propan-1-amine (CAS: 2228572-71-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique thiophene-based structure, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, pharmacological properties, and mechanisms of action, positioning it as a candidate for further drug development.

One of the key areas of interest is the compound's interaction with central nervous system (CNS) targets. Preliminary research indicates that 2,2-dimethyl-3-(5-propylthiophen-2-yl)propan-1-amine exhibits affinity for specific neurotransmitter receptors, suggesting potential applications in neurological disorders. The compound's structural features, including the propylthiophene moiety, contribute to its bioavailability and metabolic stability, making it a viable candidate for further optimization.

Recent synthetic approaches have improved the yield and purity of 2,2-dimethyl-3-(5-propylthiophen-2-yl)propan-1-amine, facilitating more robust pharmacological evaluations. Advanced techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to characterize the compound, ensuring its consistency and quality for research purposes. These advancements have enabled researchers to explore its therapeutic potential with greater precision.

In vitro and in vivo studies have provided insights into the compound's pharmacokinetic and pharmacodynamic profiles. For instance, animal models have demonstrated its ability to cross the blood-brain barrier, a critical factor for CNS-targeted therapies. Additionally, its metabolic pathways have been elucidated, revealing minimal toxicity and favorable excretion profiles. These findings underscore the compound's potential as a lead molecule for further development.

Looking ahead, ongoing research aims to explore the broader applications of 2,2-dimethyl-3-(5-propylthiophen-2-yl)propan-1-amine, including its potential use in combination therapies and as a scaffold for derivative compounds. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate its translation into clinical trials. As the body of evidence grows, this compound may emerge as a cornerstone in the development of novel therapeutics for complex diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)